Lv7
5000 积分 2022-10-20 加入
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency
1年前
已完结
Obesity and lifespan, a complex tango
1年前
已完结
PROTACs reach clinical development in inflammatory skin disease
1年前
已完结
Combining a first-in-class SLAMF7 antibody with SIRPα blockade for anti-tumor immunity
1年前
已完结
Altered cleavage of human factor VIII at the B-domain and acidic region 3 interface enhances expression after gene therapy in hemophilia A mice
1年前
已完结
CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides
1年前
已完结
CD47 masks pro-phagocytic ligands in cis on tumor cells to suppress antitumor immunity
1年前
已完结
A PD-L1xCD3 bispecific nanobody as a novel T-cell engager in treating PD-L1 overexpression melanoma
1年前
已完结
The OX40-TRAF6 axis promotes CTLA-4 degradation to augment antitumor CD8+ T-cell immunity
1年前
已完结
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
1年前
已完结
皖公网安备34019202002308
